CD8A and diffuse large B-cell lymphoma: Finally, in the light of the multivariate analysis, the significant correlation between OS and CD8+ NKs was independent of other relevant clinical parameters such as primary refractory disease, which may point to CD8+ NKs as a molecular factor with a relevant prognostic value in DLBCL.